Effects of adjuvant chemotherapy in HER2-positive or triple-negative pT1ab breast cancers: a multi-institutional retrospective study.

Olszewski, Adam J; Migdady, Yazan; Boolbol, Susan K; Klein, Paula; Boachie-Adjei, Kwadwo; Sakr, Bachir J; Sikov, William; Shao, Theresa

Olszewski, Adam J; Migdady, Yazan; Boolbol, Susan K; Klein, Paula; Boachie-Adjei, Kwadwo; Sakr, Bachir J; Sikov, William; Shao, Theresa.

Affiliation

Olszewski AJ; Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA. adam_olszewski@brown.edu

Breast Cancer Res Treat ; 138(1): 215-23, 2013 Feb.

Article in En | MEDLINE | ID: mdl-23354365

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; Breast Neoplasms/drug therapy; Breast Neoplasms/metabolism; Receptor, ErbB-2/metabolism; Aged; Antibodies, Monoclonal, Humanized/administration & dosage; Breast Neoplasms/mortality; Breast Neoplasms/pathology; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Receptor, ErbB-2/antagonists & inhibitors; Receptors, Estrogen/metabolism; Receptors, Progesterone/metabolism; Recurrence; Retrospective Studies; Trastuzumab

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 / Antibodies, Monoclonal, Humanized Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google